This once-hot cancer-detection company’s stock got cut in half after a failed trial
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to…
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to…
Russia’s economy surprised many by remaining resilient in the face of international sanctions following President Vladimir Putin’s full-scale invasion of Ukraine…